Philadelphia Trust Company Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
HONA
Honeywell Aerospace
HONA
|
+$12.8M |
| 2 |
Devon Energy
DVN
|
+$9.2M |
| 3 |
BWX Technologies
BWXT
|
+$5.1M |
| 4 |
Amgen
AMGN
|
+$2.38M |
| 5 |
SOLS
Solstice Advanced Materials
SOLS
|
+$2.37M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Honeywell
HON
|
+$11.6M |
| 2 |
CTRA
Coterra Energy
CTRA
|
+$9.74M |
| 3 |
Coherent
COHR
|
+$7.39M |
| 4 |
Abbott
ABT
|
+$7.06M |
| 5 |
AbbVie
ABBV
|
+$6.33M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 37.38% |
| 2 | Industrials | 15.01% |
| 3 | Financials | 10.63% |
| 4 | Healthcare | 8.83% |
| 5 | Miscellaneous | 7.64% |
Similar funds
Philadelphia Trust Company's Q2 2026 Portfolio in Review
As of Q2 2026, Philadelphia Trust Company held 280 positions worth $1.56B, up 10% from $1.42B the previous quarter. Its ten largest holdings account for 43% of the portfolio.
Philadelphia Trust Company withdrew a net $48.3M in Q2 2026, closing 11 positions and reducing 101 holdings. Its most notable exit was Coterra Energy, an estimated $9.74M position sold in full.
By sector, the portfolio is most concentrated in Technology at 37% of assets, up from 33% a quarter earlier, followed by Industrials and Financials.
Against the trend, Philadelphia Trust Company opened a new position in Honeywell Aerospace worth $12.9M.
- Philadelphia Trust Company's largest Q2 2026 buy was Honeywell Aerospace: 58,134 shares worth $12.9M.
- Philadelphia Trust Company added most to Devon Energy in Q2 2026, an estimated $9.2M increase.
- Philadelphia Trust Company's biggest Q2 2026 reduction was Honeywell, cutting an estimated $11.6M.
- Philadelphia Trust Company fully exited Coterra Energy in Q2 2026, selling an estimated $9.74M.
- Philadelphia Trust Company's ten largest holdings make up 43% of its $1.56B portfolio in Q2 2026.
- Philadelphia Trust Company opened 15 new positions and closed 11 in Q2 2026.
- Philadelphia Trust Company's portfolio value rose 10% quarter-over-quarter to $1.56B.
Based on Philadelphia Trust Company's 13F filing for Q2 2026, filed 10 Aug 2026.